![]() |
|
|
Vol. 301, Issue 1, 299-305, April 2002
Departments of Physiology (S.A.G., T.O.) and Respiratory Medicine
(K.S., M.O.), Juntendo University School of Medicine, Tokyo, Japan; and
Department of Medicine (K.-X.L., M.O.), Cardiovascular Pulmonary
Research Laboratory, University of Colorado Health Sciences Center,
Denver, Colorado
Cytosolic reducing cofactors, such as NADPH and NADH, are thought to
regulate vascular smooth muscle ion channel activity and vascular tone.
In this study, the effects of pentose phosphate pathway (PPP)
inhibitors, 6-aminonicotinamide (6-AN), epiandrosterone (EPI), and
dehydroepiandrosterone (DHEA), on vascular tone were studied in
isolated perfused lungs and pulmonary artery (PA) and aortic rings from
rats. In addition, effects of 6-AN on voltage-gated K+
(Kv) current in PA smooth muscle cells (SMCs) were
also examined. Pretreatment of lungs with 6-AN and EPI reduced the
pressor response to acute hypoxia and decreased tissue NADPH levels.
6-AN, EPI, and DHEA relaxed isolated PA and aortic rings precontracted
with 30 mM KCl in a dose-dependent manner. The PPP inhibitor-induced PA
relaxations were reduced in PA rings precontracted with 80 mM KCl but
not by pretreatment with nitro-L-arginine or endothelial removal. Pretreatment of PA rings with tetraethylammonium chloride or
4-aminopyridine caused rightward shifts of concentration-relaxation curves for 6-AN, EPI, and DHEA. In contrast, glybenclamide,
charybdotoxin, or apamin did not inhibit the relaxant effects of 6-AN,
EPI, and DHEA. 6-AN caused an increase in Kv current in
PASMC. These results indicate that reduction of NADPH by the PPP
inhibitors causes vasodilation at least partly through opening of
Kv channels.
This article has been cited by other articles:
![]() |
S. Serpillon, B. C. Floyd, R. S. Gupte, S. George, M. Kozicky, V. Neito, F. Recchia, W. Stanley, M. S. Wolin, and S. A. Gupte Superoxide production by NAD(P)H oxidase and mitochondria is increased in genetically obese and hyperglycemic rat heart and aorta before the development of cardiac dysfunction. The role of glucose-6-phosphate dehydrogenase-derived NADPH Am J Physiol Heart Circ Physiol, July 1, 2009; 297(1): H153 - H162. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Oka, V. Karoor, N. Homma, T. Nagaoka, E. Sakao, S. M. Golembeski, J. Limbird, M. Imamura, S. A. Gebb, K. A. Fagan, et al. Dehydroepiandrosterone upregulates soluble guanylate cyclase and inhibits hypoxic pulmonary hypertension Cardiovasc Res, June 1, 2007; 74(3): 377 - 387. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Gupte, P. M. Kaminski, B. Floyd, R. Agarwal, N. Ali, M. Ahmad, J. Edwards, and M. S. Wolin Cytosolic NADPH may regulate differences in basal Nox oxidase-derived superoxide generation in bovine coronary and pulmonary arteries Am J Physiol Heart Circ Physiol, January 1, 2005; 288(1): H13 - H21. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Fountain, A. Cheong, R. Flemming, L. Mair, A. Sivaprasadarao, and D. J. Beech Functional up-regulation of KCNA gene family expression in murine mesenteric resistance artery smooth muscle J. Physiol., April 1, 2004; 556(1): 29 - 42. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.J Zuurbier, O Eerbeek, P.T Goedhart, E.A Struys, N.M Verhoeven, C Jakobs, and C Ince Inhibition of the pentose phosphate pathway decreases ischemia-reperfusion-induced creatine kinase release in the heart Cardiovasc Res, April 1, 2004; 62(1): 145 - 153. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Gupte, M. Arshad, S. Viola, P. M. Kaminski, Z. Ungvari, G. Rabbani, A. Koller, and M. S. Wolin Pentose phosphate pathway coordinates multiple redox-controlled relaxing mechanisms in bovine coronary arteries Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2316 - H2326. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bonnet, E. Dumas-de-La-Roque, H. Begueret, R. Marthan, M. Fayon, P. Dos Santos, J.-P. Savineau, and E.-E. Baulieu Dehydroepiandrosterone (DHEA) prevents and reverses chronic hypoxic pulmonary hypertension PNAS, August 5, 2003; 100(16): 9488 - 9493. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Y. Liu, A. K. Death, and D. J. Handelsman Androgens and Cardiovascular Disease Endocr. Rev., June 1, 2003; 24(3): 313 - 340. [Abstract] [Full Text] [PDF] |
||||